Cargando…
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
The clinical approval of immune checkpoint inhibitors is an important advancement in the field of cancer immunotherapy. However, the percentage of beneficiaries is still limited and it is becoming clear that combination therapies are required to further enhance the treatment efficacy. The potential...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836981/ https://www.ncbi.nlm.nih.gov/pubmed/36571696 http://dx.doi.org/10.1007/s40259-022-00573-3 |